Speed up pharma process design and lab to production with a digital twin

Digitalization has advanced significantly, but the pharmaceutical industry still has room for improvement by leveraging digital technologies. Pharma companies can enhance process development efficiency and speed up lab-to-production transitions using digital process twins. This technology identifies and mitigates risks early, reduces costly mistakes, and optimizes operations for faster time-to-market. Digital twins offer deep process understanding, enabling virtual experiments to refine processes and ensure optimal performance. By fostering collaboration across design, engineering and manufacturing, digital process twins create a seamless lab-to-production transition, helping companies stay competitive and maximize ROI during the patent protection period.

Integrate the virtual and real worlds with the digital process twin

Pharmaceutical companies must implement the best-in-class, digital transformation technologies to ensure R&D efficiency and the ability to bring a medicine to market that meets both patient and regulatory requirements. By simulating real-world conditions and integrating data across the entire value chain, the digital process twin reduces costly and resource-intensive physical experiments, identifies potential issues early, supports virtual training and enables right-first-time production.

Download the ebook to learn more.